MetaADEDB 2.0 @ LMMD
Cariprazine hydrochloride
(GPPJWWMREQHLQT-UHFFFAOYSA-N)
Structure
SMILES
O=C(N(C)C)NC1CCC(CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl.Cl
Molecular Formula:
C21H33Cl3N4O
Molecular Weight:
463.872
Log P:
5.5313
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
38.82
CAS Number(s):
1083076-69-0
Synonym(s)
1.
Cariprazine hydrochloride
External Link(s)
PubChem Compound25096873
ChEBI90932
CHEMBLCHEMBL2024517
KEGGdr:D09876
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AkathisiaFAERS: 38US FAERS
2Drug ineffectiveFAERS: 26US FAERS
3NauseaFAERS: 19US FAERS
4Tardive DyskinesiaFAERS: 18US FAERS
5TremorFAERS: 15US FAERS
6RestlessnessFAERS: 14US FAERS
7DizzinessFAERS: 13US FAERS
8FatigueFAERS: 12US FAERS
9AnxietyFAERS: 10US FAERS
10Musculoskeletal stiffnessFAERS: 10US FAERS
11SomnolenceFAERS: 10US FAERS
12Drug dose omissionFAERS: 9US FAERS
13HeadacheFAERS: 9US FAERS
14VomitingFAERS: 9US FAERS
15AgitationFAERS: 8US FAERS
16AstheniaFAERS: 6US FAERS
17BlepharospasmFAERS: 6US FAERS
18Feeling abnormalFAERS: 6US FAERS
19Inappropriate schedule of drug administrationFAERS: 6US FAERS
20Memory impairmentFAERS: 6US FAERS
21PruritusFAERS: 6US FAERS
22SyncopeFAERS: 6US FAERS
23Drug prescribing errorFAERS: 5US FAERS
24MyalgiaFAERS: 5US FAERS
25DystoniaFAERS: 4US FAERS
26MalaiseFAERS: 4US FAERS
27NervousnessFAERS: 4US FAERS
28Neuroleptic Malignant SyndromeFAERS: 4US FAERS
29PalpitationsFAERS: 4US FAERS
30Therapeutic response unexpectedFAERS: 4US FAERS
31UrticariaFAERS: 4US FAERS
32ConstipationFAERS: 3US FAERS
33Emotional disorderFAERS: 3US FAERS
34Feeling jitteryFAERS: 3US FAERS
35HypersensitivityFAERS: 3US FAERS
36HypersomniaFAERS: 3US FAERS
37HypotensionFAERS: 3US FAERS
38Impaired driving abilityFAERS: 3US FAERS
39Limb discomfortFAERS: 3US FAERS
40Stevens-Johnson SyndromeFAERS: 3US FAERS
41TrismusFAERS: 3US FAERS
42White blood cell count decreasedFAERS: 3US FAERS
43Accidental exposure to productFAERS: 2US FAERS
44Alanine Aminotransferase IncreasedFAERS: 2US FAERS
45AlopeciaFAERS: 2US FAERS
46AmnesiaFAERS: 2US FAERS
47ArthralgiaFAERS: 2US FAERS
48Cerebrovascular accidentFAERS: 2US FAERS
49Completed SuicideFAERS: 2US FAERS
50Depressed moodFAERS: 2US FAERS
51Drug screen positiveFAERS: 2US FAERS
52HungerFAERS: 2US FAERS
53Incorrect dose administeredFAERS: 2US FAERS
54Intentional dose omissionFAERS: 2US FAERS
55Intentional product misuseFAERS: 2US FAERS
56LethargyFAERS: 2US FAERS
57Mental impairmentFAERS: 2US FAERS
58Muscle RigidityFAERS: 2US FAERS
59Muscle tightnessFAERS: 2US FAERS
60Musculoskeletal PainFAERS: 2US FAERS
61MydriasisFAERS: 2US FAERS
62NasopharyngitisFAERS: 2US FAERS
63Oromandibular dystoniaFAERS: 2US FAERS
64PainFAERS: 2US FAERS
65Peripheral swellingFAERS: 2US FAERS
66PregnancyFAERS: 2US FAERS
67Restless Legs SyndromeFAERS: 2US FAERS
68TachyphreniaFAERS: 2US FAERS
69Therapeutic product effective for unapproved indicationFAERS: 2US FAERS
70VertigoFAERS: 2US FAERS
71Visual ImpairmentFAERS: 2US FAERS
72Weight decreasedFAERS: 2US FAERS
73Wrong technique in product usage processFAERS: 2US FAERS
74Abdominal discomfortFAERS: 1US FAERS
75Accidental exposure to product by childFAERS: 1US FAERS
76Accidental overdoseFAERS: 1US FAERS
77Adverse eventFAERS: 1US FAERS
78AgranulocytosisFAERS: 1US FAERS
79Alcohol interactionFAERS: 1US FAERS
80Ammonia increasedFAERS: 1US FAERS
81Amphetamines positiveFAERS: 1US FAERS
82AngerFAERS: 1US FAERS
83AngioedemaFAERS: 1US FAERS
84AphoniaFAERS: 1US FAERS
85Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
86AutoscopyFAERS: 1US FAERS
87Back PainFAERS: 1US FAERS
88Bipolar DisorderFAERS: 1US FAERS
89Blood aldosterone decreasedFAERS: 1US FAERS
90Blood alkaline phosphatase increasedFAERS: 1US FAERS
91Blood creatine phosphokinase increasedFAERS: 1US FAERS
92Blood glucose increasedFAERS: 1US FAERS
93Blood potassium decreasedFAERS: 1US FAERS
94Body temperature fluctuationFAERS: 1US FAERS
95Borderline Personality DisorderFAERS: 1US FAERS
96CataractFAERS: 1US FAERS
97Cerebral disorderFAERS: 1US FAERS
98ChillsFAERS: 1US FAERS
99Compulsive shoppingFAERS: 1US FAERS
100CryingFAERS: 1US FAERS
101Diabetes MellitusFAERS: 1US FAERS
102DisorientationFAERS: 1US FAERS
103DroolingFAERS: 1US FAERS
104Drug effect variableFAERS: 1US FAERS
105Drug titration errorFAERS: 1US FAERS
106DysarthriaFAERS: 1US FAERS
107DysgeusiaFAERS: 1US FAERS
108DyspepsiaFAERS: 1US FAERS
109EncephalitisFAERS: 1US FAERS
110Erection increasedFAERS: 1US FAERS
111Excessive eye blinkingFAERS: 1US FAERS
112Expired product administeredFAERS: 1US FAERS
113Feeling ColdFAERS: 1US FAERS
114FibromyalgiaFAERS: 1US FAERS
115FlushingFAERS: 1US FAERS
116Food cravingFAERS: 1US FAERS
117FrostbiteFAERS: 1US FAERS
118Gait inabilityFAERS: 1US FAERS
119GamblingFAERS: 1US FAERS
120Gastric DilatationFAERS: 1US FAERS
121General physical health deteriorationFAERS: 1US FAERS
122HomosexualityFAERS: 1US FAERS
123HostilityFAERS: 1US FAERS
124Hypertensive crisisFAERS: 1US FAERS
125HyperventilationFAERS: 1US FAERS
126HypomaniaFAERS: 1US FAERS
127IncoherentFAERS: 1US FAERS
128Incorrect product dosage form administeredFAERS: 1US FAERS
129Incorrect route of drug administrationFAERS: 1US FAERS
130Intentional product use issueFAERS: 1US FAERS
131Intentional self-injuryFAERS: 1US FAERS
132Intrusive thoughtsFAERS: 1US FAERS
133LacerationFAERS: 1US FAERS
134Limb injuryFAERS: 1US FAERS
135Lip swellingFAERS: 1US FAERS
136MeningitisFAERS: 1US FAERS
137MenorrhagiaFAERS: 1US FAERS
138Mental status changesFAERS: 1US FAERS
139Multiple SclerosisFAERS: 1US FAERS
140Myoclonic EpilepsyFAERS: 1US FAERS
141Oropharyngeal painFAERS: 1US FAERS
142OverdoseFAERS: 1US FAERS
143OverweightFAERS: 1US FAERS
144ParanoiaFAERS: 1US FAERS
145Pharyngeal swellingFAERS: 1US FAERS
146PneumothoraxFAERS: 1US FAERS
147Product dispensing errorFAERS: 1US FAERS
148Product dose omissionFAERS: 1US FAERS
149Product storage errorFAERS: 1US FAERS
150Product use issueFAERS: 1US FAERS
151Psychiatric symptomFAERS: 1US FAERS
152Psychogenic seizureFAERS: 1US FAERS
153Pulmonary EmbolismFAERS: 1US FAERS
154Rash erythematousFAERS: 1US FAERS
155RetchingFAERS: 1US FAERS
156Rotator cuff syndromeFAERS: 1US FAERS
157Sedation complicationFAERS: 1US FAERS
158Sexual DysfunctionFAERS: 1US FAERS
159Skin tightnessFAERS: 1US FAERS
160SoliloquyFAERS: 1US FAERS
161Somatic symptom disorderFAERS: 1US FAERS
162Substance-induced mood disorderFAERS: 1US FAERS
163Sudden deathFAERS: 1US FAERS
164TachycardiaFAERS: 1US FAERS
165TensionFAERS: 1US FAERS
166TheftFAERS: 1US FAERS
167ThrombocytopeniaFAERS: 1US FAERS
168Tongue movement disturbanceFAERS: 1US FAERS
169Tongue spasmFAERS: 1US FAERS
170ToothacheFAERS: 1US FAERS
171Transcription medication errorFAERS: 1US FAERS
172Unevaluable eventFAERS: 1US FAERS
173Urinary RetentionFAERS: 1US FAERS
174Urinary hesitationFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.